HighTower Advisors’s TetraLogic Pharmaceuticals TLOG Stock Holding History
Bought
Maintained
Sold
Other funds holding TLOG
HighTower Advisors's TLOG Position: Q4 2016 in Review
HighTower Advisors sold out of TetraLogic Pharmaceuticals (TLOG) in Q4 2016, closing a stake of 27,870 shares — an estimated $5K sold.
HighTower Advisors first reported a position in TLOG in Q1 2014 and held it in 11 quarters. The position peaked at $424K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.
- HighTower Advisors reported no remaining TetraLogic Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- HighTower Advisors sold 27,870 TetraLogic Pharmaceuticals shares in Q4 2016, an estimated $5K.
- HighTower Advisors first reported a position in TetraLogic Pharmaceuticals in Q1 2014 and held it in 11 quarters.
- HighTower Advisors's TetraLogic Pharmaceuticals position peaked at $424K in Q1 2014.
- 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals as of Q4 2016.
Based on HighTower Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.